Name | Value |
---|---|
NAME | BREAST, NIPPLE/AREOLA |
SURGERY CODING | BREAST |
PAIRED ORGAN | LATERALITY CODE REQUIRED |
CODE | C50.0 |
DEFAULT PRIMARY SITE GROUP | BREAST |
5TH EDITION T-CODES |
|
5TH EDITION T-CODE HELP | Primary Tumor (T) T1b Tumor more than 0.5 but not more than 1 cm in greatest dimension T1c Tumor more than 1 cm but not more than 2 cm in greatest dimension T2 Tumor more than 2 cm but not more than 5 cm in greatest dimension T3 Tumor more than 5 cm in greatest dimension T4 Tumor of any size with direct extension to (a) chest wall or (b) skin, only as described below. T4a Extension to chest wall T4b Edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast T4c Both (T4a and T4b) T4d Inflammatory carcinoma TX Primary tumor cannot be assessed T0 No evidence of primary tumor Tis Carcinoma 'in situ': Intraductal carcinoma, lobular carcinoma 'in situ', or Paget's disease of the nipple with no tumor T1 Tumor 2 cm or less in greatest dimension T1mi Microinvasion 0.1 cm or less in greatest dimension T1a Tumor more than 0.1 but not more than 0.5 cm in greatest dimension |
SURGERY CODE GROUP-5TH ED | BREAST, NIPPLE/AREOLA |
5TH ED-SURGICAL APPROACH CODES |
|
5TH EDITION N-CODE HELP | Regional Lymph Nodes (N) structures N3 Metastasis to ipsilateral internal mammary lymph node(s) NX Regional lymph nodes cannot be assessed (e.g., previously removed) N0 No regional lymph node metastasis N1 Metastasis to movable ipsilateral axillary lymph node(s) N2 Metastasis to ipsilateral axillary lymph node(s) fixed to one another or to other |
5TH EDITION M-CODE HELP | Distant Metastasis (M) MX Distant metastasis cannot be assessed M0 No distant metastasis M1 Distant metastasis (includes metastasis to ipsilateral supraclavicular lymph node[s]) |
5TH ED-SURGERY PRIMARY SITE |
|
5TH ED-SURGICAL MARGINS |
|
5TH ED-SCOPE LYMPH NODE SURG |
|
5TH ED-SURGERY OTHER REG SITES |
|
5TH ED-RECONSTRUCTION |
|
5TH ED-BIOPSY PROCEDURE CODES |
|
5TH ED-GUIDANCE CODES |
|
6TH EDITION (N) CODES |
|
6TH EDITION (N) CODE HELP | Regional Lymph Nodes (N) to one another (matted) or to other structures N2b Metastasis only in clinically apparent ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastasis N3 Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or metastasis in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement N3a Metastasis in ipsilateral infraclavicular lymph node(s) N3b Metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s) N3c Metastasis in ipsilateral supraclavicular lymph node(s) NX Regional lymph nodes cannot be assessed (e.g., previously removed) N0 No regional lymph node metastasis N1 Metastasis to movable ipsilateral axillary lymph node(s) N2 Metastasis to ipsilateral axillary lymph nodes fixed or matted, or in clinically apparent ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastasis N2a Metastasis to ipsilateral axillary lymph nodes fixed |
7TH EDITION (T) CODES |
|
7TH EDITION (T) CODE HELP | Primary Tumor (T) the underlying breast parenchyma. Carcinomas in the breast parenchyma associated with Paget's disease are categorized based on the size and characteristics of the parenchymal disease, although the presence of Paget's disease should still be noted T1 Tumor <= 20 mm in greatest dimension T1mi Tumor <= 1 mm in greatest dimension T1a Tumor >1 mm but <= 5 mm in greatest dimension T1b Tumor >5 mm but <= 10 mm in greatest dimension T1c Tumor >10 mm but <= 20 mm in greatest dimension T2 Tumor >20 mm but <= 50 mm in greatest dimension T3 Tumor >50 mm in greatest dimension T4 Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules) T4a Extension to the chest wall, not including only pectoralis muscle adherence/invasion T4b Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d'orange) of the skin which do not meet the criteria for inflammatory carcinoma T4c Both T4a and T4b T4d Inflammatory carcinoma TX Primary tumor cannot be assessed T0 No evidence of primary tumor Tis Carcinoma in situ (DCIS) Ductal carcinoma in situ (LCIS) Lobular carcinoma in situ (Paget's) Paget's disease of the nipple is NOT associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in |
7TH EDITION (N) CODES |
|
7TH EDITION (N) CODE HELP | Regional Lymph Nodes (N) N0(i+) Malignant cells in regional lymph node(s) no greater than 0.2 mm (detected by H&E or IHC including ITC) N0(mol-) No regional lymph node metastases histologically, negative molecular findings (RT-PCR) N0(mol+) Positive molecular findings (RT-PCR), but no regional lymph node metastases detected by histology or IHC N1 Metastases to movable ipsilateral level I, II axillary lymph node(s) Micrometastases; or metastases in 1 to 3 axillary lymph nodes; and/or in internal mammary nodes with metastases detected by sentinel lymph node biopsy but not clinically detected N1mi Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) N1a Metastases in 1 to 3 axillary lymph nodes, at least one metastasis greater than 2.0 mm N1b Metastases in internal mammary nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected N1c Metastases in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by NX Regional lymph nodes cannot be assessed (e.g., previously sentinel lymph node biopsy but not clinically detected N2 Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases Metastases in 4 to 9 axillary lymph nodes; or in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases N2a Metastases in ipsilateral axillary lymph nodes fixed to one another (matted) or to other structures removed) Metastases in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) N2b Metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastases Metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases N3 Metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal Regional lymph nodes cannot be assessed (e.g., previously mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement Metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or in clinically detected ipsilateral internal mammary lymph nodes in the presence of 1 or more positive level I, II axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases removed, or not removed for pathologic study) detected by sentinel lymph node biopsy but not clinically detected; or in ipsilateral supraclavicular lymph nodes N3a Metastases in ipsilateral infraclavicular lymph node(s) Metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm); or metastases to the infraclavicular (level III axillary lymph) nodes N3b Metastases in ipsilateral internal mammary lymph node(s) and axillary lymph node(s) Metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of 1 or more positive axillary N0 No regional lymph node metastases lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected N3c Metastases in ipsilateral supraclavicular lymph node(s) No regional lymph node metastasis identified histologically N0(i-) No regional lymph node metastases histologically, negative IHC |
7TH EDITION (M) CODES |
|
7TH EDITION (M) CODE HELP | Distant Metastasis (M) radiographic means and/or histologically proven larger than 0.2 mm M0 No clinical or radiographic evidence of distant metastases M0(i+) No clinical or radiographic evidence of distant metastases, but deposits of molecularly or microscopically detected tumor cells in circulating blood, bone marrow or other non-regional nodal tissue that are no larger than 0.2 mm in a patient without symptoms or signs of metastases M1 Distant detectable metastases as determined by classic clinical and |
RX HOSP AND SUMM SURG BREAST |
|
RX HOSP AND SUMM RECON BREAST |
|
T & N CODES | BREAST, NIPPLE/AREOLA |
TYPE |
|
AJCC STAGING GROUP | BREAST |
T-CLASS ENCODING |
|
N-CLASS ENCODING |
|
EXTENSION CODE SET-1ST ED | BREAST |
EXTENSION CODE SET-2ND ED | BREAST |
EXTENSION CODE SET-3RD ED | BREAST |
LYMPH NODE CODE SET-1ST ED | BREAST |
LYMPH NODE CODE SET-2ND ED | BREAST |
LYMPH NODE CODE SET-3RD ED | BREAST |
SURGERY CODE SET-1ST ED | SG41 BREAST |
SURGERY CODE SET-2ND ED | SG41 BREAST |